Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide

Jpn J Ophthalmol. 2006 Nov-Dec;50(6):529-531. doi: 10.1007/s10384-006-0366-5. Epub 2006 Dec 18.

Abstract

Background: Triamcinolone acetonide (TA) has recently been used to treat diabetic macular edema (DME) but its effectiveness is limited.

Cases: Three patients (three eyes) with unresolved diffuse DME who did not respond to a posterior sub-Tenon's injection of TA underwent vitrectomy.

Observations: Intraoperatively, it was found that all of the eyes had a posterior hyaloid face that was adherent to a large area of the posterior pole retina, although this had not been detected by slit-lamp biomicroscopy or optical coherence tomography. After vitrectomy and removal of the posterior hyaloid face, there was a significant reduction in the central macular thickness of all three eyes and an improvement in the visual acuity of the patients.

Conclusions: When TA treatment is not effective for DME, vitrectomy with the complete removal of the posterior hyaloid face, including removal of the internal limiting membrane, should be considered.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Diabetic Retinopathy / diagnosis
  • Diabetic Retinopathy / drug therapy
  • Diabetic Retinopathy / surgery*
  • Drug Resistance*
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Macular Edema / diagnosis
  • Macular Edema / drug therapy
  • Macular Edema / surgery*
  • Male
  • Middle Aged
  • Tomography, Optical Coherence
  • Triamcinolone Acetonide / therapeutic use*
  • Vitrectomy / methods*
  • Vitreous Body / drug effects
  • Vitreous Body / pathology
  • Vitreous Body / surgery*

Substances

  • Glucocorticoids
  • Triamcinolone Acetonide